LIN vs MLAB · P/E 34, rev $33.99B vs P/E 81, rev $241.0M
Linde plc Ordinary Shares (LIN) versus Mesa Laboratories Inc (MLAB) — a side-by-side from cached financials, not a winner call.
Linde plc Ordinary Shares (LIN) is a specialty chemicals company listed on US.
Mesa Laboratories Inc (MLAB) is a scientific & technical instruments company listed on US.
Latest reported LIN revenue for 2025-12-31 was $33.99B. Net income was $6.90B. Revenue was up 3.0% from 2024-12-31 to 2025-12-31. LIN currently screens at market cap $223.87B and trailing P/E 34.5.
Latest reported MLAB revenue for 2025-03-31 was $241.0M. Net income was -$2.0M. Revenue was up 11.5% from 2024-03-31 to 2025-03-31. MLAB currently screens at market cap $538.3M and trailing P/E 80.5.
LIN currently screens at market cap $223.87B and trailing P/E 34.5. MLAB currently screens at market cap $538.3M and trailing P/E 80.5.
Not investment advice. Open the LIN and MLAB stock pages for the full models.
Not investment advice.